ShockWave Medical, Inc. SWAV NASDAQ

ShockWave Medical, Inc. (SWAV) reported exceptional year-over-year revenue growth of +41.4% through 2024-03 (TTM revenue vs prior-year TTM). Net income showed earnings decline of -32% YoY, reaching $55M in the latest quarter. The net profit margin is 25.3%, which is exceptional. The company has maintained profitability in all 4 quarters. The gross margin is 87% (high), up 0.2pp vs the prior year. With a $13B market cap, MOAT composite score of 72/100 (strong competitive position).

Criteria proven by this page:

• GROWTH (100/100, Partial) — growth is present but not consistently above 5% across both metrics
• PAST (50/100, Pass) — proving consistent earnings. Looking at the full 7-year annual history, the company was profitable in 2 of 7 years — a mixed long-term record
• INCOME (85/100, Pass) — proves strong profitability and pricing power
• MOAT (72/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 60/100 with 4/7 criteria passed.